Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a product name.
REQUEST A FREE TRIAL
Product
Deals
Articles
BioCentury
|
Oct 26, 2015
Clinical News
MK-3682: Interim Phase IIa data
Read More
BioCentury
|
Nov 17, 2014
Clinical News
Grazoprevir/elbasvir: Interim Phase II data
Read More
BioCentury
|
Nov 11, 2014
Clinical News
Merck reports HCV triple-combo results
Read More
BioCentury
|
Jun 16, 2014
Company News
Idenix, Merck deal
Read More
BioCentury
|
Jun 16, 2014
Strategy
Nucleotide arms race
Idenix nucleotide analog fills Merck gap in race for pan-genotype HCV regimen
Read More
BioCentury
|
Jun 10, 2014
Top Story
Merck to acquire Idenix for $3.9B
Read More
BioCentury
|
Apr 14, 2014
Clinical News
IDX21437: Phase I/II data
Read More
BioCentury
|
Apr 14, 2014
Finance
Highlights of weekly biotech stock moves
Regulatory, clinical and other milestones
Read More
BioCentury
|
Apr 8, 2014
Clinical News
Idenix reports data for IDX21437
Read More
BioCentury
|
Apr 7, 2014
Clinical News
Idenix preclinical data
Read More
Items per page:
10
1 - 10 of 11